35 studies found for:    " November 18, 2009":" December 18, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 18, 2009":" December 18, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Condition: HIV Infections
2 Unknown  HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)
Condition: HIV Infections
Interventions: Drug: Pioglitazone;   Other: Observation
3 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
4 Active, not recruiting Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions: HIV Infection;   Osteopenia;   Osteoporosis
5 Terminated Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir
Condition: HIV Infections
Intervention: Drug: Kaletra
6 Completed Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
Conditions: HIV Infection;   Rheumatic Disease;   Cancer;   Transplant;   Pediatrics
Intervention: Biological: Adjuvanted influenza A(H1N1) vaccines
7 Completed Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
Conditions: HIV Infection;   Liver Failure;   Evidence of Liver Transplantation
Intervention: Drug: Raltegravir potassium
8 Completed Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection
Conditions: H1N1 Influenza Virus;   Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Interventions: Biological: Focetria®;   Biological: Begrivac®
9 Completed Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)
Condition: HIV-1 Infections
Interventions: Drug: raltegravir; maraviroc; darunavir; ritonavir; tenofovir/emtricitabine;   Drug: darunavir; ritonavir; emtricitabine/tenofovir
10 Completed A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 formulation 1;   Drug: GSK2248761 reference formulation;   Drug: GSK2248761 formulation 3;   Drug: GSK2248761 formulation 2 or 4
11 Active, not recruiting Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Conditions: AIDS-Related Kaposi Sarcoma;   HIV Infection;   Recurrent Kaposi Sarcoma
Interventions: Drug: Bortezomib;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
12 Unknown  HIV Persistence and Viral Reservoirs
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir, tenofovir/emtricitabine
13 Completed Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers
Condition: Human Immunodeficiency Virus
Intervention: Drug: Raltegravir
14 Completed Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test
Condition: HIV Infections
Intervention: Device: In Vitro Diagnostic Device
15 Completed Pre-Exposure Prophylaxis in YMSM
Condition: HIV
Interventions: Drug: coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP;   Drug: Placebo;   Behavioral: Many Men, Many Voices (3MV)
16 Completed TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278
Condition: HIV Infections
Intervention: Drug: TMC278 (Rilpivirine) LA; Placebo
17 Completed
Has Results
Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons
Conditions: HSV Infection;   HIV Infection
Interventions: Drug: acyclovir;   Drug: valacyclovir
18 Completed Observational Study of the Therapeutic Study of Recombinant HIV-1 TAT
Condition: HIV Infection
19 Terminated Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
Conditions: HIV Infections;   Hepatitis C Virus
20 Terminated Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects
Condition: HIV Infections

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years